• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Weighing risks and benefits in treating the individual patient.

作者信息

Sinclair John C

机构信息

Department of Pediatrics, McMaster University, Room 3N11F, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.

出版信息

Clin Perinatol. 2003 Jun;30(2):251-68. doi: 10.1016/s0095-5108(03)00023-x.

DOI:10.1016/s0095-5108(03)00023-x
PMID:12875353
Abstract

Treatments may cause both benefits and harms. In such cases, the size of the benefit (indicated by the NNT to prevent one target event) needs to be weighed against the harms. One way of doing this is to estimate a threshold NNT, based on the attributable risks of the adverse events and their RVs compared with the importance of the target event prevented. By comparing the NNT at a given baseline risk with the threshold NNT, a critical baseline risk is identified above which treatment benefits are expected to outweigh harms. The assignment of RVs to benefits and harms of treatment is a necessary and crucial step in making a treatment recommendation. Consideration of the determinants of the threshold NNT may assist clinicians and parents in the explicit use of underlying values when making treatment decisions.

摘要

相似文献

1
Weighing risks and benefits in treating the individual patient.
Clin Perinatol. 2003 Jun;30(2):251-68. doi: 10.1016/s0095-5108(03)00023-x.
2
When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment.何时应使用有效治疗方法?治疗所需阈值数量和治疗最小事件发生率的推导。
J Clin Epidemiol. 2001 Mar;54(3):253-62. doi: 10.1016/s0895-4356(01)00347-x.
3
The 'number needed to treat' and the 'adjusted NNT' in health care decision-making.医疗保健决策中的“需治疗人数”与“调整后的需治疗人数”
J Health Serv Res Policy. 1998 Jan;3(1):44-9. doi: 10.1177/135581969800300110.
4
[Evidence grading system and its usage in clinical decision-making analysis].
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Apr;25(4):351-4.
5
Uncertainty in the minimum event risk to justify treatment was evaluated.评估了证明治疗合理所需的最低事件风险的不确定性。
J Clin Epidemiol. 2009 Aug;62(8):816-24. doi: 10.1016/j.jclinepi.2008.09.017. Epub 2009 Feb 12.
6
7
Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group.医学文献用户指南:XX. 将研究证据与个体患者的护理相结合。循证医学工作组。
JAMA. 2000 Jun 7;283(21):2829-36. doi: 10.1001/jama.283.21.2829.
8
Risks and benefits of glycoprotein IIb/IIIa antagonists in acute coronary syndrome.糖蛋白IIb/IIIa拮抗剂在急性冠脉综合征中的风险与获益
Ann Pharmacother. 2001 Apr;35(4):472-9. doi: 10.1345/aph.10151.
9
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.前列腺癌筛查:美国预防服务工作组推荐声明。
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710.
10
Different ways to describe the benefits of risk-reducing treatments: a randomized trial.描述降低风险治疗益处的不同方式:一项随机试验。
Ann Intern Med. 2007 Jun 19;146(12):848-56. doi: 10.7326/0003-4819-146-12-200706190-00006.

引用本文的文献

1
Methodological issues in the design and analyses of neonatal research studies: Experience of the NICHD Neonatal Research Network.新生儿研究的设计与分析中的方法学问题:美国国立儿童健康与人类发展研究所新生儿研究网络的经验
Semin Perinatol. 2016 Oct;40(6):374-384. doi: 10.1053/j.semperi.2016.05.005. Epub 2016 Jun 22.
2
Stopping guidelines for an effectiveness trial: what should the protocol specify?有效性试验的停止准则:方案应规定哪些内容?
Trials. 2016 May 10;17(1):240. doi: 10.1186/s13063-016-1367-4.
3
Predictive models for severe intraventricular hemorrhage in preterm infants.
早产儿重度脑室内出血的预测模型
J Perinatol. 2014 Oct;34(10):802. doi: 10.1038/jp.2014.152.
4
A predictive model for SIVH risk in preterm infants and targeted indomethacin therapy for prevention.预测早产儿 SIVH 风险的模型和针对该风险的预防性吲哚美辛治疗。
Sci Rep. 2013;3:2539. doi: 10.1038/srep02539.